Flavone derivatives for the treatment and prophylaxis of hepatitis B virus disease
US11708344B2 · kind B2 · utility
1Cited by
0References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 1, 2019 |
| Grant date | Jul 25, 2023 |
| Priority date | — |
| Expiry date | Oct 1, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides novel compounds having the general formula (Formula I): wherein R1 to R6, G1, G2, A1 to A4 and m are as described herein, compositions including the compounds and methods of using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.